COVID-19 Records

Transcript segment

Baric Transcribed Interview (Redacted), p.43 · baric_ti:utt:00294

Page text: p.43 · original PDF

Date
2026-04-10 09:00 (day precision)
Type
transcript segment · interview
recipient
Ralph S. Baric, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker
Christina Salazar
Can you tell me a little bit about that?

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2026-04-10 09:00 Christina Salazar open
    Okay. Can you elaborate?
  2. 2026-04-10 09:00 Ralph S. Baric open
    Well again, the whole purpose of open science is that reproducibility is key. And so if you publish an important paper, people oftentimes ask you for those reagents to either do extensive additional studies or to actually repeat the studies. And so reproducibility is key, and to do that, that's why the NIH wants you to share reagents with people that ask for things.
  3. 2026-04-10 09:00 Christina Salazar open
    But the NIH was also concerned when they later learned that potentially these mice were being sold or -- I mean, was that not a concern later on, in 2020?
  4. 2026-04-10 09:00 Ralph S. Baric open
    I don't know if NIH was concerned. I know DC.Scheduling@LexitasLegal.com that Ralph Baric was pissed off.
  5. 2026-04-10 09:00 Christina Salazar
    Can you tell me a little bit about that?
  6. 2026-04-10 09:00 Ralph S. Baric open
    Well, come on. You share an important reagent for countermeasure development to the Chinese that's important early on in their response to a pandemic that's sweeping the world, and then they try to sell it back to U.S. scientists? What kind of crap is this? This is not ethical behavior.
  7. 2026-04-10 09:00 Christina Salazar open
    How did you find out?
  8. 2026-04-10 09:00 Ralph S. Baric open
    Matt Freeman sent me an email with a little thing saying, "Hey, the Chinese are selling your mice."
  9. 2026-04-10 09:00 Christina Salazar open
    And did you confront --

Full conversation →